Claude Steriade is a Neurology physician. OpenAlex indexes 90 publications with 1,364 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Cleveland, OH 441950001
Telephone
216-444-2200Provider last certified this registry record 2 Apr 2021.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Neurelis, Inc.Program year202511 payments$13,880openpaymentsdata.cms.gov ↗
- UCB, Inc.Program year20254 payments
- SK Life Science, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
92%Other antiepileptics39.7%Levetiracetam25%Xcopri19%Lacosamide17%Vimpat11%Epidiolex7%Topiramate7%Briviact6%Keppra Xr4%Qudexy Xr3%Topamax2%Part D<11 patientsBenzodiazepine13%Clobazam44%Clonazepam22%Onfi14%Valtoco12%Nayzilam7%Part D<11 patients+ 11 more classes in this area
Metabolism & gastrointestinal
5.3%Centrally acting antiobesity products2.2%Fintepla100%Part D<11 patientsProton pump inhibitor1.5%Pantoprazole Sodium58%Rabeprazole Sodium42%Part D<11 patients+ 2 more classes in this area
Cardiovascular
1.4%Central alpha-2 Adrenergic Agonist0.7%Guanfacine Hcl Er100%Part D<11 patientsBeta blocker0.7%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Identification of Distinct Biological Groups of Patients With Cryptogenic NORSE via Inflammatory Profiling
Neurology Neuroimmunology & Neuroinflammation
2025 - Imaging brain inflammation and blood brain barrier permeability in neurological and psychiatric diseases: a review
Journal of Neuroinflammation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”